BAVIS_1170x120_1-20

O-T-C

CHPA issues statement regarding COVID-19 legislation

CHPA issues statement regarding COVID-19 legislation

WASHINGTON — Consumer Healthcare Products Association (CHPA) president and chief executive officer Scott Melville issued the following statement upon final passage of the CARES Act, which includes provisions to update and modernize the regulatory system overseeing most over-the-counter medicines and to restore O-T-C eligibility under tax-preferred HSA and FSA accounts. Scott Melville “During this unprecedented

FDA approves GSK’s Voltaren Arthritis Pain for O-T-C use

FDA approves GSK’s Voltaren Arthritis Pain for O-T-C use

WARREN, N.J. — The Food and Drug Administration has approved Voltaren Arthritis Pain as an over-the-counter remedy for arthritis pain, GlaxoSmithKline said Tuesday.  With the FDA’s approval, Voltaren Arthritis Pain becomes the first and only prescription strength, nonsteroidal anti-inflammatory (NSAID) topical gel for arthritis pain available O-T-C in the United States. Voltaren Gel, which GSK Consumer

GlaxoSmithKline, Pfizer close joint venture

GlaxoSmithKline, Pfizer close joint venture

WARREN, N.J. — GlaxoSmithKline said Thursday that it has closed a previously announced joint venture deal with Pfizer Inc. that will combine their respective consumer healthcare businesses. The move will create the world’s largest supplier of over-the-counter medications. The joint venture company will operate as GSK Consumer Healthcare. Pfizer owns a 32% equity stake in

Study: O-T-Cs save health care system billions

Study: O-T-Cs save health care system billions

WASHINGTON — Over-the-counter (O-T-C) medicines save the U.S. health care system nearly $146 billion a year, a new study has found. The report, “Value of O-T-C Medicines to the U.S. Healthcare System,” which was released by the Consumer Healthcare Products Association (CHPA), found that, on average, each dollar spent on O-T-Cs saves the national system